Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:49 PM
Ignite Modification Date:
2025-12-24 @ 12:49 PM
NCT ID:
NCT01576861
Eligibility Criteria:
Inclusion Criteria:
* Chronic Heart Failure New York Heart Association functional class II to IV, secondary to ischemic or idiopathic cardiomyopathy
* Age range 18-80 years
* Stable medication for at least one month including beta-blockers that had to be started at least 5 months before entering the study
* Left Ventricular ejection fraction 40% or less
* Growth Hormone Deficiency (defined as a peak GH response to intravenous stimulation with GHRH + Arginine \< 9 ng/ml)
* Written Informed consent
Exclusion Criteria:
* Acute proliferative or severe non-proliferative diabetic retinopathy
* Active malignancy
* Evidence of progression or recurrence of an underlying intracranial tumor
* Unstable Angina or recent myocardial infarction
* Serum Creatinine levels \> 2.5 mg/dl
* Severe liver disease (Child-Pugh B-C)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT01576861
Study Brief:
Protocol Section:
NCT01576861